Closed cell stents excel

Boston Scientific Corporation has welcomed the results of a new study, led by Dr Marc Bosiers of Belgium, demonstrating that the closed cell design of Boston Scientific’s Carotid WALLSTENT Monorail provides superior clinical outcomes compared to open cell carotid stents.

Closed cell stents provide greater plaque coverage of the carotid artery, thereby potentially reducing the risk of a delayed embolism relative to open cell stents, the company says. The study was presented in Paris at the 60th Annual Meeting of the Society for Vascular Surgery by Dr Joseph Hart, University of Rochester School of Medicine and Dentistry, Rochester, New York, who helped collect the data during his Marco Polo fellowship in Dendermonde, Belgium.

The study compares the clinical results of open versus closed cell carotid stents in 709 patients. At 30 days post procedure, symptomatic patients that received the closed cell stent showed a 4.1 times reduction of stroke, transient ischemic attacks (TIA, a major predictor of stroke) or death – compared to the open cell stent group. The Carotid WALLSTENT Monorail represented more than 70% of the closed cell stents used in this study. Closed cell stents, such as Boston Scientific’s Carotid WALLSTENT Monorail, have overlapping or fully connecting struts and cover 5 to 10 times more of the vascular wall as compared to open cell stents that have both connecting and non-connecting struts.

Latest Issues

EBME Expo 2025

Coventry Building Society Arena, UK
25th - 26th June 2025

AfPP Annual National Conference

University of Warwick
8th - 9th August 2025

Clinical Engineering Conference

Stansted Radisson Blu
23rd September 2025

Infection Prevention 2025

Brighton Centre, UK
29th - 30th September 2025